- Patients
- Professionals
- Partners in Care
- Get a Sample
Menu
September marks Vascular Awareness Month, a time to shed light on the importance of our vascular system and raise awareness about various vascular conditions. Understanding arterial and venous wounds is crucial among the many aspects of vascular health. These wounds can have different causes, presentations, and treatments. This blog discusses the differences between common arterial and venous wounds and the treatment options available for each.
Arterial wounds result from impaired blood flow through the arteries, which carry oxygen-rich blood from the heart to the body’s tissues. When arterial blood flow is compromised, the affected tissues receive inadequate oxygen and nutrients, leading to tissue damage and wound formation. Patients will typically have a history of atherosclerosis, which is a buildup of plaque in the arteries. Peripheral arterial disease, or PAD, typically affects the lower limbs.
Here are some key characteristics of arterial wounds:
Treatments to improve blood flow often include surgical revascularization procedures like angioplasty and bypass surgery may be performed. Removing dead tissue and infection control are crucial for arterial wound healing, and sharp debridement is often required.
Venous wounds, on the other hand, are a result of impaired blood flow through the veins, which carry deoxygenated blood back to the heart. When the valves in the veins malfunction or become damaged, blood can pool in the lower extremities, leading to venous insufficiency, venous hypertension and the formation of venous ulcers.
Here are some typical presentation characteristics of venous wounds:
Compression therapy is the cornerstone of venous wound management. Compression stockings or bandages are used to reduce edema and improve venous return.
Wound dressings: Specialized dressings that promote a moist wound environment and manage exudate are often employed. Keeping the leg elevated can help reduce edema and promote healing.
Vascular Awareness Month reminds us to prioritize our vascular health and understand the nuances of conditions like arterial and venous wounds. Recognizing the differences between these wounds is crucial for accurate diagnosis and effective treatment. Timely intervention and a multidisciplinary approach involving healthcare professionals, wound care specialists, vascular surgeons and physical therapists can significantly improve outcomes for patients with vascular wounds. If you or someone you know is struggling with such wounds, don’t hesitate to seek medical attention for proper evaluation and personalized care. The premiere collagen wound care products by Human BioSciences can be integral to the wound care treatment plan to facilitate increased healing potential.
For samples, just send a request to sales@humanbiosciences.com
Mrs. Vann is responsible for branding, design, and public outreach efforts for the company. Mrs. Vann has over five years of experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international. She also has experience producing several television and live-stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.
Mr. Patel is the Vice President of Operations for Human BioSciences. As such, he is responsible for strategy development for optimal growth, organizing multiple teams and implementing optimal product delivery for the growth of HBS. He has served multiple positions within HBS since 2001, including Operations Manager. With an MBA in Pharmaceutical Healthcare and a Bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge in collagen product production with a rich history in managing teams.
As the President of Human BioSciences, Dr. Rohan K Jain is responsible for the company’s overall operations, with a focus on research and development. Dr. Jain has supervised and conducted extensive research in the collagen, biomaterials, and protein space, resulting in the release of numerous new products to the market. Prior to his role at HBS, Dr. Jain was a capital markets attorney at Shearman & Sterling LLP. He received his Doctorate in Law and his MBA from New York University; his Bachelor’s degrees in Biomedical Engineering and Materials Science and his Master’s in Engineering Management from Johns Hopkins University. He is a member of the New York and Maryland bars.
Cheryl Carver, LPN, WCC, CWCA, CWCP, DAPWCA, FACCWS is responsible for clinical education and training initiatives for customer accounts. Ms. Carver has amassed a wealth of clinical knowledge and industry experience in her more than 20 years as a board-certified wound care nurse. She has authored over 200 published white papers, ebooks, blogs, and articles for WoundSource and freelance.
Dr. Goebel is responsible for the company’s physical infrastructure and global expansion efforts through partnerships. Prior to joining HBS, Dr. Goebel was Managing Director at the Graf Matuschka Group in Munich, Germany, where he was actively involved in restructuring and privatization in East Germany and Eastern Europe. He was also a member of the American group of the EBRD European Bank for Reconstruction and Development in the privatization of the Russian economy and military complex. He has over forty years’ experience in many different industries including medical devices, pharmacy, and others. Dr. Goebel earned his Doctorate and Postdoctoral degrees in Economics in East Berlin.
Mr. Kumar is responsible for the company’s overall accounting and finance activities with a focus on internal control and taxation.
Mr. Kumar has over 25 years of public and corporate accounting experience. He is a Certified Public Accountant, licensed in the State of Virginia, Maryland, and Washington D.C., and an Enrolled Agent authorized to practice before the Internal Revenue Service. Mr. Kumar is also a Chartered Accountant and fellow member of the Institute of Chartered Accountants of India. Mr. Kumar received his Master’s degree in Commerce from Himalayan University in India.
Mr. Slovick is responsible for all regulatory and quality affairs in the company. Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years. He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.
Mr. Agarwal is responsible for Corporate Business Development, Sales, and Product Development, both locally and internationally for the company. Mr. Agarwal has over six years of corporate sales and business development experience. He completed his Master of Science in Engineering Management degree from Johns Hopkins University with a technical concentration in Mechanical Engineering. In the past, he has also worked as a fundraising volunteer for three years and thus gained insights in community fundraising and business development. Additionally, he has interned at a manufacturing firm and understood various intricacies involved in manufacturing ranging from the floor level to the supply chain. He has published a paper on Omni Channel Supply Chain and is a certified Lean Six Sigma associate. He has also interned as a business development consultant to a startup for market research and pricing strategies in Israel. Equipped with a combination of management and technical background acquired from his diverse experiences and education, he is perfectly suited to lead the business development efforts for Human BioSciences.